Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
131I-TM601 in progressive/recurrent malignant melanoma
NCT00733798Phase 2Terminated
- Sponsor
- TransMolecular
- Modality
- Peptide-Drug Conjugates
- Countries
- 1
01
Overview
A Phase 2 trial of 131i-tm601 in Malignant Melanoma (MM), sponsored by TransMolecular. Status: terminated.
02
Drugs
131i-tm601
03
Conditions
Malignant Melanoma (MM)
Beyond the preview
Go deeper on NCT00733798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00733798.